Top

Supportive Care in Cancer

Published in:

01-01-2007 | Original Article

Social support and survival in patients with acute myeloid leukaemia

Authors: Martin Pinquart, Klaus Höffken, Rainer K. Silbereisen, Ulrich Wedding

Published in: Supportive Care in Cancer | Issue 1/2007

Abstract

Goal of work

The purpose of the study was to assess the effect of the reported availability of social support on the 2-year survival of patients with acute myelogenous leukaemia (AML).

Materials and methods

Fifty patients with newly diagnosed AML were asked to rate the level of available social support after diagnosis was made, but before the start of chemotherapy. Social support was assessed with the F-SozU, and information about confounding variables (age, functional status, intensity of chemotherapy, cytogenetic risk group) was collected. Univariate and multivariate Cox regression analyses were used to analyze predictors of 2-year survival.

Main results

Higher levels of available social support predicted better survival, even after controlling for age, functional status, dosage of chemotherapy, and cytogenetic risk group. Within social support, the availability of instrumental support showed more consistent associations with 2-year survival than the availability of emotional support.

Conclusions

For patients with AML, the availability of social support is relevant for decreased mortality, after accounting for age, functional impairment, dosage of chemotherapy and cytogenetic risk group.

Alferi SM, Carver CS, Antoni MH, Weiss S, Duran RE (2001) An exploratory study of social support, distress, and life disruption among low-income Hispanic women under treatment for early stage breast cancer. Health Psychol 20:41–46PubMedCrossRef

Andersen BL, Kiecolt-Glaser JK, Glaser R (1994) A biobehavioral model of cancer stress and disease course. Am Psychol 49:389–404PubMedCrossRef

Butow PN, Coates AS, Dunn SM (1999) Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol 17:3856–3860

Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edward CG, Arthur DC et al (2002) Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukaemia: results from Cancer and Leukaemia Group B (CALGB 8461). Blood 100:4325–4336PubMedCrossRef

Caplan RD, Robinson EA, French JR, Caldwell JR, Shinn M (1976) Adhering to medical regimes: pilot experiments in patient education and social support. University of Michigan, Ann Arbor, MI

Colon EA, Callies AL, Popkin MK, McClave PB (1991) Depressed mood and other variables related to bone marrow transplantation survival in acute leukaemia. Psychosomatics 32:420–425PubMed

Cox DR (1972) Regression models and life tables. J R Stat Soc 34:187–220

Cwinkel JG, Behar LC, Zabora JR (1997) Psychosocial factors that affect the survival of adult cancer patients: a review of research. J Psychosoc Oncol 15(3/4):1–34CrossRef

DeBoer MF, Ryckman RM, Pruyn JF, Van den Borne HW (1999) Psychosocial correlates of cancer relapse and survival: a literature review. Patient Educ Couns 37:215–230CrossRef

10.

Dukes Holland K, Holahan CK (2003) The relation of social support and coping to positive adaptation to breast cancer. Psychol health 18:15–29CrossRef

11.

Duric V, Stockler M (2001) Patients’ preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile. Lancet Oncol 2:691–697PubMedCrossRef

12.

Ell K, Nishimoto R, Mediansky L, Mantell J, Hamlovitch M (1992) Social relations, social support and survival among patients with cancer. J Psychosom Res 36:531–541PubMedCrossRef

13.

Fawzy FI, Fawzy NW, Hyun CS, Elashoff R, Guthrie D, Fahey JL, Morton DL (1993) Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 50:681–689PubMed

14.

Frick E, Motzke C, Fischer N, Busch R, Bumeder I (2005) Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation? Psychooncology 14:759–770PubMedCrossRef

15.

Fydrich T, Geyer M, Hessel A, Sommer G, Brähler E (1999) Fragebogen zur Sozialen Unterstützung (F-SozU): Normierung an einer repräsentativen Stichprobe [Social support questionnaire (F-SozU): norms of a representative sample]. Diagnostica 45:212–216CrossRef

16.

Giraldi T, Rodani MG, Cartei G, Grassi L (1997) Psychosocial factors and breast cancer: A 6-year follow-up study. Psychother Psychosom 66:229–236PubMedCrossRef

17.

Goodwin JS, Samet JM, Hunt WC (1996) Determinants of survival in older cancer patients. J Natl Cancer Inst 88:1031–1038PubMedCrossRef

18.

Grimwade D, Harrison H, Oliver F, Chatters S, Harrison CJ, Wheatley K et al (2001) The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukaemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98:1312–1320PubMedCrossRef

19.

Grulke N, Bailer H, Hartenstein B, Kächele H, Arnold B, Tschuschke V, Heimpel H (2005) Coping and survival in patients with leukaemia undergoing allogeneic bone marrow transplantation — long-term follow-up of a prospective study. J Psychosom Res 59:337–346PubMedCrossRef

20.

Helgeson VA, Cohen S, Fritz HL (1998) Social ties and cancer. In: Holland JC (ed) Psycho-oncology. Oxford University Press, New York, pp 99–109

21.

Hwang SS, Chang VT, Cogswell J, Aljano Y, Osenenko P, Morales E, Srinivas S, Kasimis B (2004) Study of unmet needs in symptomatic veterans with advanced cancer: incidence, independent predictors, and unmet needs outcome model. J Pain Symptom Manage 28:421–432PubMedCrossRef

22.

Kimby E, Nygren P, Glimelius B (2001) A systematic overview of chemotherapy effects in acute myeloid leukaemia. Acta Oncol 40:231–252PubMedCrossRef

23.

Kiss A, Meryn S (2001) Effect of sex and gender on psychosocial aspects of prostate and breast cancer. Br Med J 323:1056–1058CrossRef

24.

Kogon MM, Biswas A, Pearl D, Carlson EW, Spiegel D (1997) Effects of medical and psychotherapeutic treatment on the survival of women with metastatic breast cancer. Cancer 80:225–230PubMedCrossRef

25.

Kuchler T, Henne-Bruns D, Rappat S, Graul J, Holst K, Williams JI, Wood-Dauphinee S (1999) Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology 46:322–335PubMed

26.

Levy SM, Herberman BR, Whiteside T, Sanzo K, Lee J, Kirkwood J (1990) Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosom Med 52:73–85PubMed

27.

Maunsell E, Brisson J, Deschenes L (1995) Social support and survival among women with breast cancer. Cancer 76:631–637PubMedCrossRef

28.

Mrózek K, Heininen K, Bloomfield CD (2000) Prognostic value of cytogenetic findings in adults with acute myeloid leukaemia. Int J Hematol 72:261–271PubMed

29.

Nannya Y, Kanda Y, Oshima K, Kaneko M, Yamamoto R, Chizuka A et al (2002) Prognostic factors in elderly patients with acute myelogenous leukaemia: a single center study in Japan. Leuk Lymphoma 43:83–87PubMedCrossRef

30.

Naughton MJ, Herndon JE, Shumaker SA, Miller AA, Kornblith AB, Chao D, Holland J (2002) The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study to CALGB 9033. Qual Life Res 11:235–248PubMedCrossRef

31.

Osborne RH, Sali A, Aaronson NK, Elsworth GR, Mdzewski B, Sinclair AJ (2004) Immune function and adjustment style: do they predict survival in breast cancer. Psychooncology 13:199–210PubMedCrossRef

32.

Perera G, Domingo A, Villamor N, Palacious C, Junca J, Torres P, Llorente A, Fernandez C, Tormo M, de Llano MP, Bargay J, Gallart M, Florensa L, Vivancos P, Marti JM, Font L (2005) Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients. Leuk Res 29:1109–1116CrossRef

33.

Pettigrew M, Bell R, Hunter D (2003) Influence of psychological coping on survival and recurrence in people with cancer: Systematic review. Br Med J 325:1066–1076CrossRef

34.

Pieto JM, Atala J, Blanch J, Carreras E, Rovira M, Cirera E, Espinal A, Gastro C (2005) Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. J Clin Oncol 23:5878–5880CrossRef

35.

Reynolds P, Kaplan GA (1990) Social connections and risk for cancer: Prospective evidence from the Alameda County Study. Behav Med 16:101–110PubMedCrossRef

36.

Rumpold G, Augustin M, Zschocke I, Strittmatter G, Söllner W (2001) Die Validität des Hornheider Fragebogens zur psychosozialen Unterstützung bei Tumorpatienten [The validity of the Hornheide Questionnaire for psychosocial support in tumor patients]. Psychother Psychosom Med Psychol 51:25–33PubMedCrossRef

37.

Sanson-Fisher R, Girgis A, Boyes A, Bonevski B, Burton L, Cook P (2000) The unmet support care needs of patients with cancer. Cancer 88:226–237PubMedCrossRef

38.

SEER Surveillance Epidemiology and End Results. Available at http://seer.cancer.gov/

39.

Sommer G, Fydrich T (1989) Soziale Unterstützung: diagnostik, Konzepte, F-SOZU. Deutsche Gesellschaft für Verhaltenstherapie, Tübingen

40.

Soothill K, Morris SM, Harman J, Francis B, Thomas C, McIllmuray MB (2001) The significant unmet needs of cancer patients: probing psychosocial concerns. Support Care Cancer 9:597–605PubMedCrossRef

41.

Spataro V, Kovacsovich T, Bach S, Pampallona S, Schapira M, Cavalli F (2000) Acute myeloid leukaemia in the elderly: results of an individualized approach in two centres. Leuk Lymphoma 39:521–530PubMed

42.

Stavratsky KM, Donner AP, Kincade JE, Stewart MA (1988) The effect of psychosocial factors on lung cancer mortality at one year. J Clin Epidemiol 41:75–82CrossRef

43.

Turner-Cobb JM, Stephton SE, Koopman C, Blake-Mortimer J, Spiegel D (2000) Social support and salivary cortisol in women with metastatic breast cancer. Psychosom Med 62:337–345PubMed

44.

Vigano A, Bruera E, Jhangri GS, Newman SC, Fields AL, Suarez-Almazor ME (2000) Clinical survival predictors in patients with advanced cancer. Arch Intern Med 160:861–868PubMedCrossRef

45.

Vogt TM, Mulloly JP, Ernst D, Pope CR, Hollis JF (1992) Social networks as predictors of ischemic heart disease, cancer, stroke, and hypertension: Incidence, survival and mortality. J Clin Epidemiol 45:659–666PubMedCrossRef

46.

Waxler-Morrison N, Hislop TG, Mears B, Kan L (1991) Effects of social relationships on survival for women with breast cancer: a prospective study. Soc Sci Med 33:177–183PubMedCrossRef

47.

Weihs KL, Simmens SJ, Mizrahi J, Enright TM, Hunt ME, Siegel RS (2005) Dependable social relationships predict overall survival in stages II and II breast carcinoma patients. J Psychosom Res 59:299–306PubMedCrossRef

48.

Wong R, Shahajahan M, Wang X, Thall PF, De Lima M, Khouri I et al (2005) Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukaemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation. Biol Blood Marrow Transplant 11:108–114PubMedCrossRef

49.

World Health Organization (1979) WHO handbook for reporting results of cancer treatment. WHO, Geneva

Title: Social support and survival in patients with acute myeloid leukaemia
Authors: Martin Pinquart
Klaus Höffken
Rainer K. Silbereisen
Ulrich Wedding
Publication date: 01-01-2007
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 1/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-006-0114-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Goal of work

Materials and methods

Main results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2007

Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability

Palifermin improves severe mucositis, swallowing problems, nutrition impact symptoms, and length of stay in patients undergoing hematopoietic stem cell transplantation

Forthcoming Meetings

Interactive technologies and videotapes for patient education in cancer care: systematic review and meta-analysis of randomised trials

The cost of chemotherapy-induced nausea and vomiting in Italy

Feasibility of integrated home/hospital physiotherapeutic support for children with cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer